Immunotherapy treatment may be appropriate for patients with earlier stages of melanoma

Breaking News Melanoma Research

Source: University of Pittsburgh (September 20, 2021) An immunotherapy called pembrolizumab reduced cancer recurrence after surgery in patients with stage IIb and IIc melanoma, according to the results of an international, randomized phase III clinical trial led by UPMC Hillman Cancer Center. These results indicate that this immunotherapy treatment-; which currently is approved only for stage III and IV melanomas-; … Read More

USDA Accepts for Priority Review Bristol Myers Squibb’s Application for LAG-3-Blocking Antibody Relatlimab and Nivolumab Fixed-Dose Combination as Treatment for Patients with Unresectable or Metastatic Melanoma

Breaking News Melanoma Research

09/20/2021 The application is based on Phase 2/3 RELATIVITY-047 trial, in which the relatlimab and nivolumab fixed-dose combination demonstrated a statistically significant and clinically meaningful progression-free survival benefit over Opdivo monotherapy U.S. Food and Drug Administration assigns a target action date of March 19, 2022 PRINCETON, N.J.–(BUSINESS WIRE)– Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) … Read More

Nouscom Begins Phase Ib Trial of Personalized Vaccine, Keytruda Combo in Melanoma, Lung Cancer

Breaking News Melanoma Research

August 24, 2021  Expands DecisionDx®-Melanoma Coverage to Veterans Health Administration and Military Health System Medical Centers NEW YORK – Nouscom said on Tuesday it has dosed the first patient in a Phase Ib trial of its neoantigen cancer vaccine, NOUS-PEV, plus pembrolizumab (Merck’s Keytruda) in patients with advanced melanoma and non-small cell lung cancer. The trial is evaluating the combination as a … Read More

Castle Biosciences Awarded U.S. Federal Supply Schedule Contract for DecisionDx-Melanoma

Breaking News Melanoma Research

August 24, 2021 07:00 AM Eastern Daylight Time Expands DecisionDx®-Melanoma Coverage to Veterans Health Administration and Military Health System Medical Centers FRIENDSWOOD, Texas–(BUSINESS WIRE)–Castle Biosciences, Inc. (Nasdaq: CSTL), a dermatologic diagnostics company providing personalized genomic information to inform treatment decisions, today announced that it has been awarded a five-year U.S. Federal Supply Schedule (FSS) contract from the Veterans Health Administration … Read More

President’s Letter | July 2021

Presidents Update Front the desk of Samantha Guild

From the Desk of Samantha Guild I was struck several times this month with the idea that the fight against melanoma is being waged by so many people and on so many levels. Everyone can help in some way—and here at AIM, we are so appreciative of our growing community and all who want to help. You’ll read this month … Read More

FDA Orphan Drug Designation Granted to Melanoma Drug Alrizomadlin

Breaking News Melanoma Research

July 21, 2021 (repost) Sara Karlovitch The FDA has granted an orphan drug designation to alrizomadlin, an MDM2-p53 inhibitor, for the treatment of stage 2b to 4 melanoma. The FDA has granted an orphan drug designation (ODD) to alrizomadlin (APG-115), an MDM2-p53 inhibitor, for the treatment of stage 2b to 4 melanoma, according to a press release by Ascentage Pharma.1 … Read More

Heather Tebbenhoff: AIM’s new Director of Community Engagement

By Alicia Rowell, Vice President It’s like the job description was written for her. Heather Tebbenhoff brings a wealth of experience to her new role as Director of Community Engagement for AIM at Melanoma. In fact, she’s held this same role for the last five years at her previous non-profit, one focused on literacy. Before that, she worked in a … Read More

Chad Freitas and the Skiff Sailing Foundation

By Alicia Rowell, Vice President It was 1986. Chad Freitas was six years old, and he and his dad drove from the Bay Area of California to Vancouver, Canada in an old VW to see Expo86, the World’s Fair. Featuring exhibits from all around the world, the 1986 expo presented the theme of transportation. Young Chad was struck by Australia’s … Read More

The Psychological Well-Being of Skin Cancer Patients

By Alicia Rowell, Vice President With a mom who is a professor of Research Methods in Applied Psychology at the University of Southern California, perhaps it’s not surprising that 16-year-old Madeleine Lepley is already dipping her toe in the research field. Madeleine lives in Lexington, KY, and attends Lafayette High School, a public school near her home. Last year, her … Read More